| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/30/2011 | CN101579347B Breast perfusion preparation for treating mammitis of milk cow in lactation period and preparation method thereof |
| 03/30/2011 | CN101569614B Puerarin lagging cover slowly-releasing dripping pill and preparing method thereof |
| 03/30/2011 | CN101559074B Coccidiostat-decoquinate dry suspension for livestock and poultry and preparation method thereof |
| 03/30/2011 | CN101544662B Cefotiam salt compound and pharmaceutical composition made therefrom |
| 03/30/2011 | CN101507733B Nano micromolecule hyaluronic acid and preparation method thereof |
| 03/30/2011 | CN101491518B Combination for treating tumor |
| 03/30/2011 | CN101485637B Colchicine framework controlled release tablets or capsules |
| 03/30/2011 | CN101480453B Hepatinica for egg-shaped pompano |
| 03/30/2011 | CN101475583B Dibutyl tin dichloride schiff alkali coordination compound, as well as preparation method and application thereof |
| 03/30/2011 | CN101440118B Saponin compound extracted from Momordica grosvenori root, preparation and use thereof |
| 03/30/2011 | CN101433546B Capecitabine sustained and controlled release oral formulation and preparation method thereof |
| 03/30/2011 | CN101429202B Cephalosporium acremonium corda rhzomorph, production method and uses thereof |
| 03/30/2011 | CN101428037B Anti-apolexis composition containing repair factor |
| 03/30/2011 | CN101416950B Preparation method of cmellia sponin controlled release tablets |
| 03/30/2011 | CN101401942B Azelnidipine composition |
| 03/30/2011 | CN101401922B Traditional Chinese medicine for preventing and controlling rhagadia and frostbite, and preparation method thereof |
| 03/30/2011 | CN101401866B Proprietary Chinese medicine medical ointment for treating radiation dermatitis |
| 03/30/2011 | CN101397241B Ent-abieta diterpenoid largeleaf rabdosia leaf I and J, preparation method and use thereof |
| 03/30/2011 | CN101396495B Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 03/30/2011 | CN101390851B Double-cyclitol medicine composition containing surfactant and preparation method thereof |
| 03/30/2011 | CN101385821B Asthma control coating agent and preparation technique thereof |
| 03/30/2011 | CN101384587B Heterocyclic antiviral compounds |
| 03/30/2011 | CN101375948B External-use formulation for impotence and preparation method thereof |
| 03/30/2011 | CN101375872B Novel medicament prescription for treating diabetes |
| 03/30/2011 | CN101375839B Grifola frondosa polysaccharide soft capsules and preparation method thereof |
| 03/30/2011 | CN101353430B Method for preparing amylose water solution |
| 03/30/2011 | CN101352483B Medicine for treating diabetes |
| 03/30/2011 | CN101327203B Gallic acid chelates composition and uses thereof |
| 03/30/2011 | CN101317816B Docetaxel long-circulation formulation |
| 03/30/2011 | CN101309746B Method for production of single- and multi-layer microcapsules |
| 03/30/2011 | CN101306003B Use of cyaniding 3-0 glucoside in preparing medicament or food for preventing and curing atrophic arthritis |
| 03/30/2011 | CN101283968B Tolterodine fumarate oral solid preparation and preparation method thereof |
| 03/30/2011 | CN101282722B Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 03/30/2011 | CN101242825B Use of L-carnitine and/or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops |
| 03/30/2011 | CN101235061B Novel alpha-amylase inhibitor alcaftadine series compounds and application thereof |
| 03/30/2011 | CN101190180B Metoprolol sustained release medicinal compositions and preparation method thereof |
| 03/30/2011 | CN101185643B Application of (E)-1-(2, 4-dihydroxy-5-(3-methyl-butyl-2-alkenyl) phenyl)-3-(4-hydroxy-phenyl) propylene-2-ketone-1 in medicine |
| 03/30/2011 | CN101182345B Ursolic acid oxazoline new drugs having antiphlogistic activity and preparation method thereof |
| 03/30/2011 | CN101182289B 4'-hydroxy-4,6'-dimethoxy dihydrocharcone and method for synthesizing the same |
| 03/30/2011 | CN101181559B Preparation method of Chinese medicine preparation for curing fungi dermatosis |
| 03/30/2011 | CN101167697B Donepezils compound long-acting slow-releasing and controlled-releasing composition and preparation method thereof |
| 03/30/2011 | CN101133049B Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol |
| 03/30/2011 | CN101133027B Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 03/30/2011 | CN101115488B Pharmaceutical use of atraric acid |
| 03/30/2011 | CN101112448B Donkey-hide gelatin composition having immunity improving effect and method of making the same |
| 03/30/2011 | CN101111508B Spiroketal derivative and use thereof as diabetic medicine |
| 03/30/2011 | CN101103993B Hypoglycemic medicine composition |
| 03/30/2011 | CN101099739B Enrofloxacin gelatine microball and its preparation method |
| 03/30/2011 | CN101085811B SARS coronavirus pharmaceutical target and application thereof |
| 03/30/2011 | CN101085045B Traditional Chinese medicine preparation for treating stomatitis |
| 03/30/2011 | CN101080224B Application and compositions for treating pain |
| 03/30/2011 | CN101080216B Compositions comprising polymeric emulsifiers and methods of using same |
| 03/30/2011 | CN101068550B Pharmaceutical formulation of carboxamide HIV integrase inhibitors containing a release rate controlling composition |
| 03/30/2011 | CN101045163B High molecular anticarcinogenic prodrug, its preparing method and use |
| 03/30/2011 | CN101007790B Oxamic acid derivative, and its preparation method and medicinal uses |
| 03/29/2011 | US7915450 Transfection reagents |
| 03/29/2011 | US7915448 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists |
| 03/29/2011 | US7915433 Tri-substituted 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6 disubstituted pyran derivatives |
| 03/29/2011 | US7915420 Aryl piperidine amides |
| 03/29/2011 | US7915419 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/29/2011 | US7915417 Amino methylated 2-pyridinones |
| 03/29/2011 | US7915413 Compounds |
| 03/29/2011 | US7915410 Acyclic IKur inhibitors |
| 03/29/2011 | US7915408 Triazolotriazines as kinase inhibitors |
| 03/29/2011 | US7915405 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives for therapeutic agent of antiinflammatory disease, method thereof for preparation, therapeutic agent for antiinflammatory disease induced by SPC activity containing the same |
| 03/29/2011 | US7915400 RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA) |
| 03/29/2011 | US7915381 Immunomodulatory flagellin peptide having at least about 10 amino acids; immunotherapy treatment of cancer |
| 03/29/2011 | US7915317 substantially free of glyceryl esters of medium or long chain fatty acids; propofol red blood cell-blood plasma partition coefficient, Kp, for the composition is at least about twice the Kp obtained upon administration of a conventional propofol emulsion under the same delivery conditions |
| 03/29/2011 | US7915315 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 03/29/2011 | US7915313 Inhibitors of yeast filamentous growth and method of their manufacture |
| 03/29/2011 | US7915312 Topical application to the eye of an acetylcholinesterase inhibitor such as echothiophate iodide to treat color blindness, ocular hypertension and glaucoma, and progression of myopia Strabismus Stargardts or pupil dilation. |
| 03/29/2011 | US7915310 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 03/29/2011 | US7915309 Deuterium-enriched oseltamivir |
| 03/29/2011 | US7915308 Therapeutic methods and compositions involving isoflavones |
| 03/29/2011 | US7915307 Methods of improving the pharmacokinetics of doxepin |
| 03/29/2011 | US7915306 Macrocyclic compounds useful as pharmaceuticals |
| 03/29/2011 | US7915305 To treat autoimmune, inflammatory, proliferative, hyperproliferative,neurodegenerative or immunologically-mediated diseases; useful for the study of kinases in biological and pathological phenomena; study of intracellular signal transduction pathways mediated by such kinases, and comparative evaluation |
| 03/29/2011 | US7915304 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT |
| 03/29/2011 | US7915303 Glycopyrronium salts and their therapeutic use |
| 03/29/2011 | US7915302 Crystal forms of pyrrolylheptanoic acid derivatives |
| 03/29/2011 | US7915301 Inhibitors of cyclin dependent kinases and their use |
| 03/29/2011 | US7915300 Cysteine protease inhibitors |
| 03/29/2011 | US7915299 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes |
| 03/29/2011 | US7915298 Compounds and methods for leukotriene biosynthesis inhibition |
| 03/29/2011 | US7915297 Isoxazole derivatives and use thereof |
| 03/29/2011 | US7915295 Viricides; HIV antivirals effective against problematic drug escape mutants; N-[(1S,1aR,7bR)-4,7-difluoro-1,1a,2,7b-tetrahydrocyclopropa[c]chromen-1-yl]-N'-[5-(4-(sulfonamido)phenoxy)-2-pyridinyl]urea |
| 03/29/2011 | US7915294 Method of treating colorectal carcinoma |
| 03/29/2011 | US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases |
| 03/29/2011 | US7915292 2-{benzyl-[(6-methyl-2-phenyl-quinolin-3-yl)-phenyl-methyl]-amino}-N-(4-methyl-piperazin-1-yl)-acetamide; tuberculosis; antimycobacterial drugs; a tertiary nitrogen atom in the alpha position in the side chain attached to the 3-position of the quinoline nucleus to get fewer enantiomers possible |
| 03/29/2011 | US7915291 Hepatitis C virus inhibitors |
| 03/29/2011 | US7915290 Argatroban formulations and methods for making and using same |
| 03/29/2011 | US7915288 1-aryl-4-substituted isoquinolines |
| 03/29/2011 | US7915287 Substituted heterocycles and methods of use |
| 03/29/2011 | US7915286 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| 03/29/2011 | US7915285 Method for treating drug and behavioral addictions |
| 03/29/2011 | US7915284 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 03/29/2011 | US7915283 e.g. 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione; viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators |
| 03/29/2011 | US7915281 Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915276 Berberrubine derivatives having antifungal activities |